অনুসন্ধান ফলাফলগুলি - Wolfgang Petritsch
- প্রদর্শন 1 - 9 ফলাফল এর 9
-
1
-
2
The efficacy and safety of either infliximab or adalimumab in 362 patients with anti‐<scp>TNF</scp>‐α naïve Crohn's disease অনুযায়ী Neeraj Narula, Stephanie Kainz, Wolfgang Petritsch, Thomas Haas, T Feichtenschlager, Gottfried Novacek, Alexander Eser, Harald Vogelsang, Walter Reinisch, Pavol Papay
প্রকাশিত 2016Artigo -
3
Antibiotic-Associated Apoptotic Enterocolitis in the Absence of a Defined Pathogen: The Role of Intestinal Microbiota Depletion* অনুযায়ী Philipp Wurm, Walter Spindelboeck, Robert Krause, Johannes Plank, G. Fuchs, Mina Bashir, Wolfgang Petritsch, Bettina Halwachs, Cord Langner, Christoph Högenauer, Gregor Gorkiewicz
প্রকাশিত 2017Artigo -
4
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease অনুযায়ী Wolfgang Miehsler, Gottfried Novacek, H Wenzl, Harald Vogelsang, P Knoflach, Arthur Kaser, Clemens Dejaco, Wolfgang Petritsch, Magdalena Kapitan, Harald Maier, W. Graninger, Herbert Tilg, Walter Reinisch
প্রকাশিত 2010Artigo -
5
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI অনুযায়ী Herbert Lochs, Michael Mayer, Wolfgang E. Fleig, Preben Bo Mortensen, Péter Bauer, Dieter Genser, Wolfgang Petritsch, Martin Raithel, Rainer Hoffmann, Volker Groß, Mathias Plauth, Michael Staun, L. B. Nesje
প্রকাশিত 2000Artigo -
6
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a ran... অনুযায়ী Walter Reinisch, Sieglinde Angelberger, Wolfgang Petritsch, Olga Shonová, Milan Lukáš, Simon Bar–Meir, Alexander Teml, Elke Schaeffeler, Matthias Schwab, K. Dilger, Roland Greinwald, Ralph Müeller, Eduard F. Stange, Klaus R. Herrlinger
প্রকাশিত 2010Artigo -
7
The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative coliti... অনুযায়ী Patrizia Kump, Philipp Wurm, H Gröchenig, H Wenzl, Wolfgang Petritsch, Bettina Halwachs, Matthew A. Wagner, Vanessa Stadlbauer, Andreas Eherer, K. Martin Hoffmann, A Deutschmann, G Reicht, Ludwig Reiter, P. Slawitsch, Gregor Gorkiewicz, Christoph Högenauer
প্রকাশিত 2017Artigo -
8
Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism অনুযায়ী Gottfried Novacek, Ansgar Weltermann, Anna Sobala, Herbert Tilg, Wolfgang Petritsch, Walter Reinisch, Andreas Mayer, Thomas Haas, Arthur Kaser, T Feichtenschlager, H Fuchssteiner, P Knoflach, Harald Vogelsang, Wolfgang Miehsler, Reingard Platzer, W Tillinger, Bernhard Jaritz, Alfons Schmid, B Blaha, Clemens Dejaco, Sabine Eichinger
প্রকাশিত 2010Artigo -
9
Clinical presentation of venous thromboembolism in inflammatory bowel disease অনুযায়ী Pavol Papay, Wolfgang Miehsler, Herbert Tilg, Wolfgang Petritsch, Walter Reinisch, Andreas Mayer, Thomas Haas, Arthur Kaser, T Feichtenschlager, H Fuchssteiner, P Knoflach, Harald Vogelsang, Reingard Platzer, W Tillinger, Bernhard Jaritz, Alfons Schmid, B Blaha, Clemens Dejaco, Anna Sobala, Ansgar Weltermann, Sabine Eichinger, Gottfried Novacek
প্রকাশিত 2012Artigo
অনুসন্ধান সাধনীগুলি:
সম্পর্কিত বিষয়
Internal medicine
Medicine
Disease
Gastroenterology
Inflammatory bowel disease
Crohn's disease
Surgery
Antibiotics
Biology
Genetics
Immunology
Microbiology
Adverse effect
Bacteria
Clinical trial
Clostridium difficile
Deep vein
Discontinuation
Gut flora
Infliximab
Pulmonary embolism
Randomized controlled trial
Thrombosis
Ulcerative colitis
Adalimumab
Akkermansia
Akkermansia muciniphila
Alternative medicine
Antibiotic-associated diarrhea
Apoptosis